Can Lisinopril (angiotensin-converting enzyme inhibitor) cause memory loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril and Memory Loss

Lisinopril is not specifically associated with memory loss in current clinical guidelines, though certain antihypertensive medications like beta-blockers have been linked to cognitive effects.

Evidence on ACE Inhibitors and Cognition

The relationship between ACE inhibitors like lisinopril and cognitive function has been examined in several guidelines:

  • The European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines note that hypertension itself is associated with cognitive dysfunction and various forms of dementia 1
  • These guidelines further state that lowering blood pressure can slightly improve cognitive performance and memory, though not learning capacity 1
  • The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure acknowledges that hypertension and hypercholesterolemia are risk factors for mild cognitive impairment 1

Cognitive Effects of Different Antihypertensive Classes

Different classes of antihypertensive medications have varying cognitive profiles:

  • Beta-blockers (like propranolol) have been documented to cause memory impairment, particularly affecting verbal memory 2
  • The Joint National Committee guidelines specifically mention that beta-blockers and alpha-blockers can cause orthostatic hypotension, which may indirectly affect cognition 1
  • There is no specific mention of ACE inhibitors like lisinopril causing memory loss in the major hypertension guidelines 1

Lisinopril's Pharmacological Profile

Lisinopril's pharmacological characteristics make it less likely to cause cognitive side effects:

  • Unlike some other antihypertensive medications, lisinopril is not highly lipophilic and does not significantly cross the blood-brain barrier 3, 4
  • Clinical reviews of lisinopril in elderly patients do not highlight memory loss or cognitive impairment as significant concerns 5
  • The drug's safety profile is generally favorable, with adverse effects described as "relatively minor" 4

Management Considerations

When evaluating a patient with suspected medication-related cognitive effects:

  1. Rule out other causes of cognitive impairment:

    • Assess for hypoglycemia, which can worsen cognitive function 1, 6
    • Consider vascular dementia, which is more common in hypertensive patients 1
    • Evaluate for white matter lesions, which are associated with hypertension 1
  2. Consider medication adjustments if necessary:

    • If cognitive symptoms persist and appear temporally related to lisinopril initiation, consider alternative antihypertensive agents
    • Calcium channel blockers have shown beneficial effects on cognitive outcomes in some studies 1
  3. Monitor cognitive function:

    • Use validated tools like Montreal Cognitive Assessment (MoCA) or Mini-Mental State Examination (MMSE) 6
    • Perform regular cognitive reassessments (annually recommended) 6

Conclusion

While memory loss is not a commonly reported side effect of lisinopril in clinical guidelines, individual responses to medications can vary. If a patient experiences memory issues while taking lisinopril, a thorough evaluation should be conducted to rule out other causes before attributing the symptoms to the medication.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Impairment of memory function by antihypertensive medication.

Archives of general psychiatry, 1983

Research

The clinical pharmacology of lisinopril.

Journal of cardiovascular pharmacology, 1987

Guideline

Management of Cognitive Impairment in Patients with Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.